Literature DB >> 11388666

E2F-1 induced apoptosis.

A C Phillips1, K H Vousden.   

Abstract

Members of the E2F family of transcription factors play an important role in regulating the cell cycle, and their activity is often perturbed during the development of human malignancies. More recent work has shown that E2F-1 regulates apoptosis as well as proliferation, in part by stabilizing the p53 tumor suppressor, an important mediator of apoptosis. This has led to the suggestion that E2F-1 may function as a tumor surveillance mechanism, detecting aberrant proliferation and engaging apoptotic pathways to protect the organism from developing tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11388666     DOI: 10.1023/a:1011332625740

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  34 in total

1.  Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viability.

Authors:  Vassiliki Poulaki; Constantine S Mitsiades; Antonia M Joussen; Alexandra Lappas; Bernd Kirchhof; Nicholas Mitsiades
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2.

Authors:  Harry A Rogoff; Mary T Pickering; Fiona M Frame; Michelle E Debatis; Yolanda Sanchez; Stephen Jones; Timothy F Kowalik
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

3.  Upregulation of E2F1 in cerebellar neuroprogenitor cells and cell cycle arrest during postnatal brain development.

Authors:  Daniela E Suzuki; Carolina B Ariza; Marimélia A Porcionatto; Oswaldo Keith Okamoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-05-26       Impact factor: 2.416

4.  TNF-α response of vascular endothelial and vascular smooth muscle cells involve differential utilization of ASK1 kinase and p73.

Authors:  S Rastogi; W Rizwani; B Joshi; S Kunigal; S P Chellappan
Journal:  Cell Death Differ       Date:  2011-07-08       Impact factor: 15.828

5.  Novel role of PELP1 in regulating chemotherapy response in mutant p53-expressing triple negative breast cancer cells.

Authors:  Samaya R Krishnan; Binoj C Nair; Gangadhara R Sareddy; Sudipa Saha Roy; Mohan Natarajan; Takayoshi Suzuki; Yan Peng; Ganesh Raj; Ratna K Vadlamudi
Journal:  Breast Cancer Res Treat       Date:  2015-03-19       Impact factor: 4.872

6.  p63 and p73 in tumor suppression and promotion.

Authors:  Frank D McKeon
Journal:  Cancer Res Treat       Date:  2004-02-29       Impact factor: 4.679

7.  Functional interplay between E2F1 and chemotherapeutic drugs defines immediate E2F1 target genes crucial for cancer cell death.

Authors:  David Engelmann; Susanne Knoll; Daniel Ewerth; Marc Steder; Anja Stoll; Brigitte M Pützer
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

8.  Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model.

Authors:  Laura A Lambert; Na Qiao; Kelly K Hunt; Donald H Lambert; Gordon B Mills; Laurent Meijer; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

9.  Identification and expression analysis of two zebrafish E2F5 genes during oogenesis and development.

Authors:  Qiwen Yang; Jiarui Hu; Ding Ye; Cailian Zhao; Shan Song; Wuming Gong; Zheng Tan; Ping Song
Journal:  Mol Biol Rep       Date:  2009-07-04       Impact factor: 2.316

10.  Elucidation of functional consequences of signalling pathway interactions.

Authors:  Adaoha E C Ihekwaba; Phuong T Nguyen; Corrado Priami
Journal:  BMC Bioinformatics       Date:  2009-11-06       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.